key: cord-0266125-mez45hux authors: Hüfner, K.; Tymoszuk, P.; Ausserhofer, D.; Sahanic, S.; Pizzini, A.; Rass, V.; Galffy, M.; Böhm, A.; Kurz, K.; Sonnweber, T.; Tancevski, I.; Kiechl, S.; Huber, A.; Plagg, B.; Wiedermann, C.; Bellmann-Weiler, R.; Bachler, H.; Weiss, G.; Piccoliori, G.; Helbok, R.; Löffler-Ragg, J.; Sperner-Unterweger, B. title: Who is at risk of poor mental health following COVID-19 outpatient management? date: 2021-09-26 journal: nan DOI: 10.1101/2021.09.22.21263949 sha: 83e4af8a8d14299825ad17e2a90a4b8f58c63387 doc_id: 266125 cord_uid: mez45hux Background: COVID-19 convalescents are at risk of developing a de novo mental health disorder or of worsening of a pre-existing one. The objectives of our study was to phenotype individuals at highest risk of mental health disorders among COVID-19 outpatients. Methods: We conducted a binational online survey study with adult non-hospitalized COVID-19 convalescents (Austria/AT: n=1157, Italy/IT: n= 893). Primary endpoints were positive screening for depression and anxiety (PHQ-4, Patient Health Questionnaire) and self-perceived overall mental health and quality of life rated with 4 point Likert scales. Psychosocial stress was surveyed with a modified PHQ stress module. Associations of the mental health with socio-demographic variables, COVID-19 course and recovery data were assessed by multi-parameter random forest and serial univariable modeling. Mental disorder risk subsets were defined by self-organizing map and hierarchical clustering algorithms. The survey analyses are publicly available (https://im2-ibk.shinyapps.io/mental_health_dashboard/). Results: In the study cohorts, 4.6 (IT)/6% (AT) of participants reported depression and/or anxiety before to infection. At a median of 79 days (AT)/96 days (IT) post COVID-19 onset, 12.4 (AT)/19.3% (IT) of subjects were screened positive for anxiety and 17.3 (AT)/23.2% (IT) for depression. Over one-fifth of the respondents rated their overall mental health (AT: 21.8%, IT: 24.1%) or quality of life (AT: 20.3%, IT: 25.9%) as fair or poor. In both study collectives, psychosocial stress, high numbers of acute and persistent COVID-19 complaints and the presence of acute neurocognitive symptoms (impaired concentration, confusion, forgetfulness) were the strongest correlates of deteriorating mental health and poor quality of life. In clustering analysis, these variables defined a high risk subset with particularly high propensity of post-COVID-19 mental health impairment and decreased quality of life. Pre-existing depression or anxiety was associated with an increased symptom burden during acute COVID-19 and recovery. Conclusion: Our study revealed a bidirectional relationship between COVID-19 symptoms and mental health. We put forward specific acute symptoms of the disease as red flags of mental health deterioration which should prompt general practitioners to identify COVID-19 patients who may benefit from early psychological and psychiatric intervention. Trial registration: ClinicalTrials.gov: NCT04661462. Prevalence of mental health disorders rose during the COVID-19 pandemic in the general population from 4% in 2006(1) to 20% for depression and from 5% in 2008(2) to 19% for anxiety as of March 2020 (3) . The mental health deterioration following COVID-19 was described primarily for hospitalized subjects (4) . The frequency of depression or anxiety in inpatients was estimated for approximately 25% at 5 -12 months post infection (5) (6) (7) . A real-world analysis of 62,354 COVID-19 in-and outpatients at 14 -90 days follow-up revealed the overall incidence of psychiatric conditions at 18.1% [95%CI: 17.6 to 18.6], out of which 5.8% [5.2-6.4 ] comprised de novo disorders (8) . In this study, a pre-existing mental illness was put forward as a risk factor for SARS-CoV-2 infection suggestive of a bi-directional relationship between psychiatric conditions and COVID-19 (8) . A large, medical record-based comparison of long-term sequelae in COVID-19 and non-COVID- 19 healthcare system users revealed an excess of sleep/wake-(relative risk: 14.5 [11. 5-17.3] ), anxiety/fear-(5.4 [3.4-7.3] ) and trauma/stress-related disorders (8.9 [6.6-11.1]) in COVID-19 patients (9) . Still, the prevalence and risk factors of mental health conditions and diminished quality of life in COVID-19 outpatients, which may be missed from medical record analyses, are insufficiently characterized. The binational 'Health after COVID-19 in Tyrol' study aims at exploring the disease course as well as physical and mental recovery in two cohorts of non-hospitalized convalescents(10). Herein, using multi-parameter modeling we sought to assess the impact of demographics, socioeconomics, comorbidities, COVID-19 disease symptoms and course and the psychosocial stress on the anxiety, depression, self-perceived overall mental health and quality of life. By association analysis, we aimed to identify individuals at risk of worsening mental health and quality of life, which may particularly benefit from early psychological and psychiatric support. Finally, we made the study results publicly available as an online dashboard (https://im2-ibk.shinyapps.io/mental_health_dashboard/)(11). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; https://doi.org/10.1101/2021.09. 22 .21263949 doi: medRxiv preprint The multi-center online survey study 'Health after COVID-19 in Tyrol' (ClinicalTrials.gov: NCT04661462) was conducted between the 30 th September 2020 and 11 th July 2021 in two cohorts independently recruited in Tyrol/Austria (AT) and South Tyrol/Italy (IT)(10). The study inclusion criteria were residency in the study regions, age of ≥16 (AT) or ≥18 years (IT) and a laboratoryconfirmed SARS-CoV-2 infection (PCR or seropositivity). The respondents with a minimum observation time of < 28 days between the infection diagnosis and survey completion or hospitalized because of COVID-19 were excluded from the analysis (Figure 1) . The participants were invited by a public media call (AT and IT) or by their general practitioners (IT). The study was conducted in accordance with the Declaration of Helsinki and the European data policy. Each participant gave a digitally signed informed consent to participate. The study protocol was approved by the institutional review boards of the Medical University of Innsbruck (AT, approval number: 1257/2020) and of the Autonomous Province of Bolzano -South Tyrol (IT: 0150701). The detailed description of the questionnaire variables is provided by Sahanic is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Pre-existing depression/anxiety or sleep disorders were surveyed as single question each (yes/no). Self-perceived overall mental health (OMH) and quality of life (QoL) were rated with a 4-point Likert scale ('excellent', 'good', 'fair', 'poor', scored: 0, 1, 2, 3). Anxiety and depression at the survey completion were investigated using PHQ-4 questionnaire(11,13), with ≥ 3 point cutoffs for the clinical signs of depression (DPR) or anxiety (ANX). Psychosocial stress was measured with a modified 7 item (answers: 'no', 'little', 'some', 'a lot', scored: 0, 1, 2, 3) PHQ stress module(11, 14) , without items on weight, sexuality and past traumatic/serious events; the item on worries/dreams was adapted to COVID-19. The stress scoring was re-coded as quartile strata encompassing 0 -2, 3 -4, 5 -6, 7 -21 points. Substantial psychosocial stress was defined by a ≥ 7 point cutoff. Data were analyzed with R version 4.0.5 (15, 16) . Statistical significance of variable median or distribution differences between groups was determined by U, Kruskal-Wallis or χ 2 test, as appropriate. Categorical variable co-occurrence was assessed by Cohen's κ and Z test. P values were corrected for multiple comparisons with Benjamini-Hochberg method (17) . Random forest models for ANX, DPR, OMH and QoL scoring were built and cross-validated (10 fold) separately in the AT and IT cohort (18, 19) . To account for possible effects of diagnosissurvey time, a stratified observation time variable was included in the models (Supplementary Table S1 ). The factor's influence on the scoring variable was measured by the difference in model's mean squared error (ΔMSE) as described in (18) . To assess the factor impact on the combined mental health and quality of life rating, centered principal component analysis (PCA) with factor's normalized values of ΔMSE for the OMH, QoL, ANX and DPR scoring was performed (20) . The factors with the 10 largest PCA loadings in each cohort were used further for univariable modeling and clustering. Univariable modeling was accomplished with age-and sex-weighted Poisson regression(10). Clustering was done with the self-organized map procedure (SOM, 11×11 unit 7 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; https://doi.org/10.1101/2021.09.22.21263949 doi: medRxiv preprint hexagonal grid, Jaccard distance) and subsequent hierarchical clustering (Ward D2 algorithm, Euclidean distance) (21, 22) . Details of statistical analysis are provided in Supplementary Methods. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint In total, 1157 questionnaires in the AT and 893 in the IT cohort were analyzed (Figure 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; psychosocial stress in 21.3 (AT)/25.6% (IT) of the respondents. Except for the poor/rair rating of self-perceived OMH and QoL, the studied mental status features demonstrated only weak cooccurrence (Cohen's κ < 0.5, Supplementary Figure S1) . Importantly, the investigated mental health and quality of life rating variables were weakly associated with the observation time (Supplementary Figure S2 and (11) ). The QoL rating as well as prevalence of ANX, DPR and substantial stress were significantly higher in the IT than in the AT study collective ( Table 3 and (11)). To identify the crucial factors impacting the ANX, DPR, OMH and QoL scoring, we applied the random forest machine learning modeling (18) to a set of 145 explanatory variables in the AT and IT cohorts (Supplementary Table S1 ). Such models demonstrated good performances in the training data sets (Spearman's ρ > 0.9, means absolute error (MAE): 0.21 -0.44) and 10-fold crossvalidation (MAE: 0.51 -1.1) (Supplementary Figures S3 -S6) . The high and moderate psychosocial stress levels (>75 th and >50 th percentile) affected the ANX, OMH and QoL rating to the greatest extent in each cohort (Supplementary Figures S3, S5 -S6 ). In turn, high psychosocial stress values along with acute concentration deficits and persistent tiredness displayed the tightest association with the DPR score (Supplementary Figure S4) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; among the most influential factors for the ANX, DPR, OMH and QoL scoring in at least one study cohort (Supplementary Figures S3 -S6 ). To discern features influencing the combined mental health and quality of life scoring, principal component analysis was performed (20) . This approach underscored the prime effect of moderate and psychosocial stress on the rating in both the AT and IT collective, followed by persistent tiredness and acute neurocognitive manifestations such as confusion, concentration and memory deficits as well as acute and persistent symptom burden (Figure 2 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; subset differed from the IR cluster by higher proportions of subjects with > 3 persistent symptoms, persistent tiredness and fatigue (Figure 4, Supplementary Figure S9) . Notably, the HR followed by the IR group demonstrated significantly worse ANX, DPR, OMH and QoL rating as well as higher frequencies of anxiety (AT: 5.3% in LR, 24% in HR, IT: 9.7% in LR, 44% in HR) and depression (AT: 4.9% in LR, 34.8% in HR, IT: 11.3% in LR, 40.3% in HR) compared with the IR cluster ( Figure 5 and (11)). In addition, chest, abdomen and joint pain complaints, diminished appetite, sleep problems, dizziness and tachycardia during acute COVID-19 were significantly more frequent in the IR and HR cluster than in the LR subset (Supplementary Finally, we sought to investigate whether a reciprocal link between the pre-existing psychiatric disorder and the burden of acute and persistent COVID-19 symptoms exists. Participants declaring anxiety/depression before the infection had a 20% higher median burden of overall acute COVID-19 symptoms and >30% more acute neurocognitive symptoms compared with the depression/anxiety-free subset (Figure 6A -C) . In addition, pre-existing depression/anxiety was linked to a significantly higher prevalence of long COVID both in the AT (depression/anxiety: 65.2% vs depression/anxiety-free: 46.4% long COVID, p = 0.0037, χ 2 test) and IT cohort (68.3% vs 48.4% long COVID, p = 0.020, χ 2 test). Accordingly, significantly higher counts of persistent overall and neurocognitive symptoms were observed in the pre-COVID-19 depression/anxiety subset compared with the depression/anxiety-free subjects (Figure 6D -F is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; https://doi.org/10.1101/2021.09.22.21263949 doi: medRxiv preprint neurocognitive complaints during acute COVID-19 (5, 7, 9, 10, 12, (25) (26) (27) were found frequently accompanied by lower-respiratory, cardiological and neurological symptoms and sleep disorders (7, 10, 27) . and posed unfavorable correlates long COVID risk(10). Herein, the acute neurocognitive features together with high symptom burden of acute COVID-19, multiple acute pain manifestations and sleep problems defined the IR and HR Mental Disorder Risk Clusters of the participants likely to develop a mental health condition in course of the recovery. Such 'red flags' of deteriorating mental health present in the first two weeks of COVID-19 may be exploited for early diagnosis and psychological or psychiatric intervention. Pre-existing depression or anxiety was reported by roughly 5% of the respondents and was linked to mental health deficits during recovery -a phenomenon known from non-COVID-19 medical conditions (28) . Concomitantly, the subset with pre-existing depression/anxiety was found to experience a significantly higher burden of acute symptoms and post-acute sequelae. Conspicuously, psychiatric disorders before COVID-19 were described as an age-and other comorbidity-independent risk factor for SARS-CoV-2 infection (8) . This indicates that alike chronic somatic diseases, pre-existing mental health conditions may predispose the patient to more severe and poly-symptomatic COVID-19. Several mechanisms might mediate the bidirectional associations of COVID-19, depression, anxiety and psychosocial stress (29) . Protracted systemic inflammation is an important pathogenetic factor in depressive-anxious disorders during COVID-19 convalescence (7, 10, 24, (30) (31) (32) . Stress being the key co-variate of poor mental health in the study collectives was proposed to modulate anti-SARS-CoV-2 immunity culminating in more severe COVID-19 (33) and to perpetuate the systemic low- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Each participant gave a digitally signed informed consent to participate. The study protocol was approved by the institutional review boards of the Medical University of Innsbruck (AT, approval number: 1257/2020) and of the Autonomous Province of Bolzano -South Tyrol (IT: 0150701). Not applicable. The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Analysis of the psychosocial features is available as an online dashboard (https://im2-ibk.shinyapps.io/mental_health_dashboard). The complete R analysis pipeline is available at https://github.com/PiotrTymoszuk/mental-health-after-COVID-19. PT owns his data science enterprise, Data Analytics as a Service Tirol. PT has also received an honorarium for the study data management, curation and analysis and minor manuscript work. The author has no other competing interests to declare. Other authors have no competing interests to declare. The study was funded by the Research Fund of the State of Tyrol, Austria (Project GZ 71934, JLR). . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table S1 ) on the overall mental health, quality of life, anxiety and depression scoring were modeled with random forest technique (Supplementary Figures S3 -S6) . The the impacts of candidate factors on the model fits were subjected to two-dimensional centered principal component analysis. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; https://doi.org/10.1101/2021.09.22.21263949 doi: medRxiv preprint P values corrected for multiple comparisons with Benjamini-Hochberg method are shown in the plots. N numbers of individuals assigned to the clusters are presented next to the plots. . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 26, 2021. ; https://doi.org/10.1101/2021.09.22.21263949 doi: medRxiv preprint Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population The effect of age, gender, income, work, and physical activity on mental health during coronavirus disease (COVID-19) lockdown in Austria Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Physical, cognitive and mental health impacts of COVID-19 following hospitalisation -a multi-centre prospective cohort study. medRxiv Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry High-dimensional characterization of post-acute sequalae of COVID-19 Health after COVID-19 in Tyrol. Mental Health after COVID-19 in Tyrol Attributes and predictors of long COVID A 4-item measure of depression and anxiety: Validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population Gesundheitsfragebogen für Patienten (PHQ-D)". Ergebnisse der Deutschen validierungsstudie Welcome to the Tidyverse Elegant Graphics for Data Analysis Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Random forests Building predictive models in R using the caret package Algorithms for Projection-Pursuit robust principal component analysis Self-Organizing Maps Springer Series in Information Sciences Clustering of the self-organizing map A basic introduction to fixed-effect and random-effects models for meta-analysis Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors Long COVID in a prospective cohort of home-isolated patients Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res Characterizing long COVID in an international cohort: 7 months of symptoms and their impact Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes: Results of a prospective longitudinal study over one year Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated with SARS-CoV-2 Infection Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun Depression, Anxiety, and Acute Stress Disorder Among Patients Hospitalized With Coronavirus Disease 2019: A Prospective Cohort Study Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up We acknowledge the commitment of the participants, healthcare administration and general practitioners to the study and daily management of the COVID-19 pandemic.